BJL
ROIV icon

Brighton Jones LLC’s Roivant Sciences ROIV Stock Holding History

Brighton Jones LLC’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$344K Sell
9,719
-722
-7% -$21.3K 0.01% 979
2026
Q1 		$289K Buy
+10,441
New +$268K 0.01% 950

Other funds holding ROIV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Brighton Jones LLC's ROIV Position: Q2 2026 in Review

Brighton Jones LLC reduced its Roivant Sciences (ROIV) stake by 6.9% in Q2 2026, selling an estimated $21.3K and leaving 9,719 shares worth $344K. The position accounts for 0.01% of the portfolio, ranked #979.

Brighton Jones LLC first reported a position in ROIV in Q1 2026 and has held it in 2 quarters since. 266 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Brighton Jones LLC held 9,719 shares of Roivant Sciences worth $344K as of Q2 2026.
  • Brighton Jones LLC sold 722 Roivant Sciences shares in Q2 2026, an estimated $21.3K.
  • Roivant Sciences made up 0.01% of Brighton Jones LLC's portfolio in Q2 2026, its #979 holding.
  • Brighton Jones LLC first reported a position in Roivant Sciences in Q1 2026 and has held it in 2 quarters since.
  • 266 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Brighton Jones LLC's 13F filing for Q2 2026, filed 11 Aug 2026.